[ad_1] The Bureau of Labor Statistics’ (BLS’) Prescription Drug Consumer Price Index (CPI‐Rx) looks at price changes for drugs dispensed at outpatient retail pharmacies. However, many pharmaceuticals–especially infusions and injections–are
[ad_1] By MATTHEW HOLT I am dipping into two rumbling controversies that probably only data nerds and chronic care management nerds care about, but as ever they reveal quite a
[ad_1] By KIM BELLARD Among the many things that infuriate me about the U.S. healthcare system, health systems sending their patients to collections – or even suing them – is
[ad_1] For patients with serious illnesses, timeline access to efficacious medications is paramount. The European Medicines Agency (EMA) was created in part to help expedite drug approvals and insure these
[ad_1] By KELLY CARROLL There is a dire need to raise awareness about heart disease in women. It is the number one killer of American women, and key data points
[ad_1] By MIKE MAGEE How comfortable is the FDA and Medical Ethics community with a new super-charged medical Facial Recognition Technology (mFRT) that claims it can “identify the early stages
[ad_1] A paper by Kogut (2024) has a nice overview of the organizations that develop pharmacy plan quality metrics. Pharmacy plan quality is vital since approximately 85% of the US
[ad_1] By KMI BELLARD I’ve been thinking a lot about infrastructure. In particular, what to do when it fails. There was, of course, the tragic collapse of Baltimore’s Francis Scott
[ad_1] The Digital Therapeutics Alliance defines a digital therapeutic (DTx) as “evidence-based therapeutic interventions that are driven by high-quality software programs to prevent, manage, or
[ad_1] By Jeff Goldsmith Years ago, the largest living thing in the world was thought to be the blue whale. Then someone discovered that the largest living thing in the